Adults who have been diagnosed with attention deficit hyperactivity disorder (ADHD) may be living shorter lives than they should, finds a world-first study led by UCL researchers.
4D Molecular Therapeutics’ gene therapy cuts Eylea use in wet AMD patients, biotech divulges plans for pivotal studies
4D Molecular Therapeutics said people with wet age-related macular degeneration (AMD) who received the company’s gene therapy as part of a clinical trial needed fewer